NEW YORK, NY — February 27, 2020 — InvestorsHub NewsWIre — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has commenced the production of its proprietary Cannabigerol (“CBG”) isolate infused version of Tauri-Gum™ (“CBG Tauri-Gum™”). Each blister pack of this CBG Tauri-Gum™ will contain 8 tablets of chewing gum (10mg CBG per tablet). The flavor that has been selected for this CBG Tauri-Gum™ is Peach-Lemon(instead of Starfruit-Peach, as originally contemplated). The product will be Kosher Certified, Vegan Formulated, NON-GMO, Gluten-Free, and Allergen-Free. The MSRP has been set at $19.99 per Blister Pack / $199.99 per Retail Box.
Over the past two months, the Company has experienced strong levels of interest and indications of demand for this CBG infused version of Tauri-Gum™. The Company believes that this product is truly innovative and has the potential to enhance the value of its Tauri-Gum™ brand as well as drive revenue growth.
Cannabigerol (“CBG”) is a non-psychoactive cannabinoid that plays an important role in the biochemistry of the cannabis plant. CBG acts as a chemical precursor to other cannabinoids such as THC and CBD. This conversion typically takes place 6-8 weeks in the flowering cycle. CBG is present only in trace amounts in most cannabis strains however, some hemp strains are specifically cultivated to generate higher yields of this cannabinoid.
CBG holds promise to be a key constituent in the overall medicinal benefits cannabis may provide. As cannabis research continues to rapidly evolve, CBG may emerge as one of the most therapeutically applicable and diverse cannabinoids to offer a wide range of possible remedies.
CBG is not scheduled by the UN Convention on Psychotropic Substances. In the United States, it is not a controlled substance under the Controlled Substances Act as long as it is not produced from the controlled parts of the cannabis plant.
The Company expects that its “Peach-Lemon Flavor” CBG Infused version of Tauri-Gum™ will be available to the retail marketplace, during late March 2020.
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases. This CBD infused chewing gum product has been branded under the following name: Tauri-Gum™. The Company is currently in production of three distinct flavors of Tauri-Gum™: MINT, BLOOD ORANGE, and POMEGRANATE. On December 6, 2019 the Company announced that it completed the initial production run (thereby expanding its existing product lines) with the introduction of a 25mg Vegan CBD Isolate Infused vegan gummy (“gum drop”), branded under the name: Tauri-Gummies™. Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: [email protected]
cell # (917) 796 9926
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com